Hims & Hers Health, Inc. has announced its acquisition of ZAVA, a leading European digital health platform, marking a significant expansion into the European market.
Information on the Target
Hims & Hers Health, Inc. (NYSE:HIMS) is a leading health and wellness platform based in San Francisco, recognized for its innovative approaches to accessible healthcare. The company has recently made a strategic decision to expand its global presence by acquiring ZAVA, a prominent digital health platform in Europe. ZAVA, which serves over 1.3 million active customers, is renowned for its commitment to providing high-quality, dependable healthcare, having delivered nearly 2.3 million consultations across the UK, Germany, France, and Ireland in 2024.
This acquisition will enable Hims & Hers to penetrate the European market more robustly, officially launching its services in key nations such as Germany, France, and Ireland. By leveraging ZAVA's existing platform and infrastructure, Hims & Hers aims to offer personalized healthcare tailored to the needs of European customers.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The digital health industry in Europe is experiencing significant growth, driven by increasing demand for personalized healthcare solutions. Consumers are now more inclined than ever to seek convenient methods for managing
Similar Deals
STEMCELL Technologies → Cellular Highways Ltd
2025
Hims & Hers Health, Inc.
invested in
ZAVA
in 2025
in a Other deal